Position in INCY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,013,559
+$15,547 QoQ
Shares Held
42,643
+5.3% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $117,481,189 across 42 Biotechnology names. INCY ranks #5 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,893 | $47,732,000 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,517 | $32,850,334 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,472 | $9,751,400 | |
| 4 | INSM |
INSMED Inc
|
48,193 | $7,880,519 | |
| 5 | INCY |
Incyte Corp
This page
|
42,643 | $4,013,559 | |
| 6 | MRNA |
Moderna, Inc.
|
78,526 | $3,989,120 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,856 | $1,821,574 | |
| 8 | RPRX |
Royalty Pharma plc
|
30,224 | $1,449,845 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,013,559 | 42,643 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,998,012 | 40,478 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,127,119 | 25,081 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,660,482 | 24,383 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,595,613 | 26,352 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,829,871 | 26,493 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,672,528 | 25,303 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,490,039 | 24,580 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,557,388 | 27,337 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,666,195 | 26,536 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,595,722 | 27,622 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,741,194 | 27,971 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,041,121 | 28,243 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,208,880 | 27,501 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,739,970 | 26,110 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,834,599 | 24,149 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,531,852 | 19,288 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,401,940 | 19,100 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,674,647 | 38,887 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,218,729 | 38,259 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,990,492 | 36,797 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,976,020 | 34,215 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,865,308 | 31,929 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $3,174,827 | 30,536 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $2,154,573 | 29,422 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||